检索结果 - Silvia Bader‐Weder

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy

    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy 由 Jennifer M. Kwon, Kapil Arya, Nancy L. Kuntz, Han C. Phan, Cory Sieburg, Kathryn J. Swoboda, Aravindhan Veerapandiyan, Beverly Assman, Silvia Bader‐Weder, Travis L. Dickendesher, Jennifer L. Hansen, Helen Lin, Ying Yan, Vamshi K. Rao

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment

    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment 由 Eugenio Mercuri, Giovanni Baranello, Odile Boespflug‐Tanguy, Liesbeth De Waele, Nathalie Goemans, Janbernd Kirschner, Riccardo Masson, Elena Mazzone, Astrid Pechmann, Maria Carmela Pera, Carole Vuillerot, Silvia Bader‐Weder, Marianne Gerber, Ksenija Gorni, Janine Hoffart, Heidemarie Kletzl, Carmen Martín, Tammy McIver, R. Scalco, Wai Yin Yeung, Laurent Servais

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: